金种子酒预亏1.9亿！5年亏超6亿，华润也扶不起？

Core Viewpoint - Jinzhongzi Liquor (600199.SH) has announced a projected net loss for 2025, estimating a loss of between 190 million to 150 million yuan, with a non-recurring net profit loss of 210 million to 170 million yuan [10][12] Group 1: Financial Performance - The company has reported a cumulative net loss exceeding 600 million yuan over the past five years, marking its fifth consecutive year of losses since 2021 [5][12] - For the first three quarters of 2025, Jinzhongzi Liquor's operating revenue was 628 million yuan, with a net profit loss of 100 million yuan, compared to a loss of 99.53 million yuan in the same period last year [6][13] - The revenue from the liquor business was 512 million yuan, with low-end liquor accounting for 330 million yuan (64.45%), mid-range liquor for 131 million yuan (25.59%), and high-end liquor only 5.13 million yuan [6][13] Group 2: Inventory and Efficiency - As of the third quarter of 2025, the company's inventory reached 1.531 billion yuan, representing 76.13% of total current assets of 2.011 billion yuan [14] - The inventory turnover rate for the first three quarters of 2025 was only 0.23 times, a decrease of 30.3% year-on-year, indicating weakened inventory digestion capability [15] Group 3: Corporate Governance and Management Changes - Since the entry of China Resources Group in 2022, Jinzhongzi Liquor has attempted to implement management and brand restructuring, but the expected improvements have not materialized [7][16] - The company has seen significant management turnover, with the resignation of the general manager in July 2025 and subsequent departures of key executives, leading to a vacancy in the general manager position for nearly six months [16] - Despite a loss of 258 million yuan in 2024, executive compensation increased, leading to significant shareholder dissent during the annual meeting [8][16] Group 4: Asset Sales and Financial Strategies - To alleviate financial pressure, Jinzhongzi Liquor sold 92% of its subsidiary, Jintaiyang Pharmaceutical, for 126 million yuan in November 2025 [17] - The company has been actively selling assets, including nearly 100 properties valued at approximately 162 million yuan and transferring land use rights for 4.25 million yuan to its controlling shareholder [17]